Trial site
Centro de Investigaciones Medicas Tucuman
- 30running trials
- 9closed trials
The trials here
What the 39 trials at this site are about, from their registry records.
- Conditions
- Lupus (SLE)12 trials
- Psoriasis4 trials
- Migraine3 trials
- Multiple sclerosis3 trials
- Chronic spontaneous urticaria2 trials
- Dermatomyositis and polymyositis (myositis)2 trials
- Psoriatic arthritis2 trials
- Rheumatoid arthritis2 trials
- Systemic sclerosis (scleroderma)2 trials
- Type 2 diabetes2 trials
- Ulcerative colitis2 trials
- Atopic dermatitis (eczema)1 trial
- and 7 more
- Phase
- Phase 326 trials
- Phase 210 trials
- Phase 2/32 trials
- Status
- Active, not recruiting17 trials
- Recruiting9 trials
- Completed8 trials
- Enrolling by invitation3 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Janssen Research & Development, LLC8 trials
- Hoffmann-La Roche4 trials
- Biogen3 trials
- Boehringer Ingelheim3 trials
- H. Lundbeck A/S3 trials
- and 13 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Active, not recruiting
Active, not recruiting
A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis
Recruiting
Enrolling by invitation
Recruiting
Active, not recruiting
Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)
Active, not recruiting
Active, not recruiting
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
Active, not recruiting
A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis
Active, not recruiting
Enrolling by invitation
Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus
Active, not recruiting
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
Recruiting
Active, not recruiting
A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
Recruiting
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Active, not recruiting
Active, not recruiting
The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)
Active, not recruiting
Enrolling by invitation
Active, not recruiting
Recruiting
Active, not recruiting
A Long-term Extension Study of Ustekinumab in Pediatric Participants
Active, not recruiting
Recruiting
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lupus (SLE)5 recruiting
- Migraine3 recruiting
- Chronic spontaneous urticaria1 recruiting
- Colorectal cancer1 recruiting
- Dermatomyositis and polymyositis (myositis)1 recruiting
- Myasthenia gravis1 recruiting
- Rheumatoid arthritis1 recruiting
Closed trials
Completed
Terminated
Study of Daxdilimab (HZN-7734) in Participants With Active Proliferative Lupus Nephritis (LN)
Completed
Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
Completed
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
Completed
Completed
Completed
The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)
Completed
Completed
A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus
Site data: ClinicalTrials.govUpdated 19 Nov 2026